193 related articles for article (PubMed ID: 32580298)
1. Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment.
Fang JH; Liu CH; Hsu RS; Chen YY; Chiang WH; Wang HD; Hu SH
Polymers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580298
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of carboxymethyl cellulose/hyaluronic acid/polyvinylpyrrolidone composite pastes incorporation of minoxidil-loaded ferulic acid-derived lignin nanoparticles and valproic acid for treatment of androgenetic alopecia.
Li P; Sun Y; Nie L; Shavandi A; Yunusov KE; Hua Y; Jiang G
Int J Biol Macromol; 2023 Sep; 249():126013. PubMed ID: 37517761
[TBL] [Abstract][Full Text] [Related]
3. Microneedle Delivery Platform Integrated with Codelivery Nanoliposomes for Effective and Safe Androgenetic Alopecia Treatment.
Zhang S; Zhou H; Chen X; Zhu S; Chen D; Luo D; Chen S; Liu W
ACS Appl Mater Interfaces; 2024 Apr; 16(13):15701-15717. PubMed ID: 38507687
[TBL] [Abstract][Full Text] [Related]
4. Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model.
Kim MJ; Seong KY; Kim DS; Jeong JS; Kim SY; Lee S; Yang SY; An BS
Acta Biomater; 2022 Apr; 143():189-202. PubMed ID: 35202857
[TBL] [Abstract][Full Text] [Related]
5. Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment.
Ding YW; Li Y; Zhang ZW; Dao JW; Wei DX
Bioact Mater; 2024 Aug; 38():95-108. PubMed ID: 38699241
[TBL] [Abstract][Full Text] [Related]
6. Dissolving microneedles for alopecia treatment.
Xiang H; Xu S; Zhang W; Xue X; Li Y; Lv Y; Chen J; Miao X
Colloids Surf B Biointerfaces; 2023 Sep; 229():113475. PubMed ID: 37536169
[TBL] [Abstract][Full Text] [Related]
7. Conditioned media-integrated microneedles for hair regeneration through perifollicular angiogenesis.
Yuan A; Gu Y; Bian Q; Wang R; Xu Y; Ma X; Zhou Y; Gao J
J Control Release; 2022 Oct; 350():204-214. PubMed ID: 35961471
[TBL] [Abstract][Full Text] [Related]
8. An androgenetic alopecia remedy based on marine collagen peptide-incorporated dissolving microneedles.
Zheng W; Wang F; Tao N; Wang X; Jin X; Zhang C; Xu C
Int J Pharm; 2024 Jan; 650():123629. PubMed ID: 37992979
[TBL] [Abstract][Full Text] [Related]
9. Promotion of Hair Regrowth by Transdermal Dissolvable Microneedles Loaded with Rapamycin and Epigallocatechin Gallate Nanoparticles.
Lin Y; Shao R; Xiao T; Sun S
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890299
[TBL] [Abstract][Full Text] [Related]
10. Ceria Nanozyme-Integrated Microneedles Reshape the Perifollicular Microenvironment for Androgenetic Alopecia Treatment.
Yuan A; Xia F; Bian Q; Wu H; Gu Y; Wang T; Wang R; Huang L; Huang Q; Rao Y; Ling D; Li F; Gao J
ACS Nano; 2021 Aug; 15(8):13759-13769. PubMed ID: 34279913
[TBL] [Abstract][Full Text] [Related]
11. Three Dimensional Printing and Its Applications Focusing on Microneedles for Drug Delivery.
Al-Nimry SS; Daghmash RM
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376046
[TBL] [Abstract][Full Text] [Related]
12. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a Layer-by-Layer Microbubbles-Based Delivery System for Applying Minoxidil to Enhance Hair Growth.
Liao AH; Lu YJ; Lin YC; Chen HK; Sytwu HK; Wang CH
Theranostics; 2016; 6(6):817-27. PubMed ID: 27162552
[TBL] [Abstract][Full Text] [Related]
14. Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W/O/W solvent evaporation and sonication.
Takeuchi I; Hida Y; Makino K
Biomed Mater Eng; 2018; 29(2):217-228. PubMed ID: 29457595
[TBL] [Abstract][Full Text] [Related]
15. Microneedle for transdermal drug delivery: current trends and fabrication.
Jung JH; Jin SG
J Pharm Investig; 2021; 51(5):503-517. PubMed ID: 33686358
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo assessment of polymer microneedles for controlled transdermal drug delivery.
Chen BZ; Ashfaq M; Zhang XP; Zhang JN; Guo XD
J Drug Target; 2018 Sep; 26(8):720-729. PubMed ID: 29301433
[TBL] [Abstract][Full Text] [Related]
17. Triton modified polyethyleneimine conjugates assembled with growth arrest-specific protein 6 for androgenetic alopecia transdermal gene therapy.
Fan X; Zhao X; Xu J; Wang J; Wang Q; Tang X
Mater Today Bio; 2023 Apr; 19():100575. PubMed ID: 36815198
[TBL] [Abstract][Full Text] [Related]
18. Trilayer dissolving microneedle for transdermal delivery of minoxidil: a proof-of-concept study.
Afika N; Saniy AF; Fawwaz Dharma AA; Ko CK; Kamran R; Permana AD
J Biomater Sci Polym Ed; 2024 May; ():1-21. PubMed ID: 38718083
[TBL] [Abstract][Full Text] [Related]
19. Microneedle-based drug delivery systems for transdermal route.
Pierre MB; Rossetti FC
Curr Drug Targets; 2014 Mar; 15(3):281-91. PubMed ID: 24144208
[TBL] [Abstract][Full Text] [Related]
20. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
